Cargando…
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy
BACKGROUND AND AIM: The long-term prognosis of hepatocellular carcinoma (HCC) treated at a very-early-stage (the Barcelona Clinical Liver Cancer (BCLC) classification stage 0) was unclear, especially in terms of background liver disease. METHODS: This single-center, retrospective study included 302...
Autores principales: | Takaura, Kenta, Kurosaki, Masayuki, Inada, Kento, Kirino, Sakura, Yamashita, Kouji, Muto, Tomohiro, Osawa, Leona, Sekiguchi, Shuhei, Hayakawa, Yuka, Higuchi, Mayu, Kaneko, Shun, Maeyashiki, Chiaki, Tamaki, Nobuharu, Yasui, Yutaka, Itakura, Jun, Tsuchiya, Kaoru, Nakanishi, Hiroyuki, Takahashi, Yuka, Izumi, Namiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865683/ https://www.ncbi.nlm.nih.gov/pubmed/35196341 http://dx.doi.org/10.1371/journal.pone.0264075 |
Ejemplares similares
-
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
por: Inada, Kento, et al.
Publicado: (2021) -
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup
por: Tamaki, Nobuharu, et al.
Publicado: (2020) -
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy
por: Sekiguchi, Shuhei, et al.
Publicado: (2022) -
Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma
por: Kirino, Sakura, et al.
Publicado: (2020) -
Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib
por: Kaneko, Shun, et al.
Publicado: (2020)